• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis

    2023-12-29 13:42:14JuanYangLinaChaYepengWangQuanZhangXiaopengTangJianlinShaoandZileiDuan
    Natural Products and Bioprospecting 2023年6期

    Juan Yang,Lina Cha,Yepeng Wang,Quan Zhang,Xiaopeng Tang,Jianlin Shao and Zilei Duan*

    Abstract l-Palmitoylcarnitine (L-PC) is an important endogenous fatty acid metabolite.Its classical biological functions are involved in the regulations of membrane molecular dynamics and the β-oxidation of fatty acids.Decreased plasma long-chain acylcarnitines showed the association of venous thrombosis,implying anticoagulant activity of the metabolites and inspiring us to investigate if and how L-PC,a long-chain acylcarnitine,takes part in coagulation.Here we show that L-PC exerted anti-coagulant effects by potentiating the enzymatic activities of plasmin and tissue plasminogen activator (tPA).L-PC directly interacts with plasmin and tPA with an equilibrium dissociation constant (KD)of 6.47 × 10-9 and 4.46 × 10-9 M,respectively,showing high affinities.In mouse model,L-PC administration significantly inhibited FeCl3-induced arterial thrombosis.It also mitigated intracerebral thrombosis and inflammation in a transient middle cerebral artery occlusion (tMCAO) mouse model.L-PC induced little bleeding complications.The results show that L-PC has anti-thrombotic function by potentiating plasmin and tPA.

    Keywords l-palmitoylcarnitine,Coagulation,Plasmin,Tissue-type plasminogen activator,Thrombosis

    1 Introduction

    L-PC is a well-known intermediate in mitochondrial fatty acid oxidation.L-PC is synthesized through the catalyzation of palmitoyl-CoA and L-carnitine (L-C),which is present in various food items and an essential nutrient for energy production and fatty acid metabolism [1].L-C supplementation has also been shown to reduce serum C-reactive protein,a marker of systemic inflammation,and plasma fibrinogen in hemodialysis patients [2],although the underlying mechanism remains unclear.In comparison to L-C,the role of L-PC has been less extensively studied.L-PC has been implicated in the pathology of cardiac ischemia [3].L-PC was found to be accumulated in the ischemic heart due to the inhibition of mitochondrial β-oxidation of fatty acid.It also induces membrane dysfunction in ischemic myocardium via Ca2+-dependent and -independent mechanisms [4,5].Moreover,it causes disorders of vascular endothelium [6,7].L-PC potentiates the functions of caspases to take part in apoptosis [8].Therefore,the amphipathic metabolite L-PC,acts as one of key molecules in ischemia induced cell damage and induces elevation of intracellular Ca2+level in various types of cells [9].Some of remarkable physicochemical properties of L-PC,such as amphiphilicity and longchain (> 10 carbons),may be involved in the pathogenesis of myocardial ischemia,which are unrelated to mitochondrial fatty acid metabolism [3].The physicochemical properties of L-PC may contribute to lipidclotting factor interactions to regulate the functions of clotting factors and blood coagulation [10].However,it is unknown if and how L-PC affects coagulation.

    In this study,we found the long-chain acylcarnitine L-PC has direct interactions with two enzymes plasmin and tPA,which are related to fibrin (ogen)olysis.L-PC potentiated the enzymatic activities of plasmin and tPA to promote fibrin (ogen)olysis.Mouse models showed anti-coagulant and anti-thrombotic functions of L-PC.The study revealed the regulatory function of L-PC on coagulation and intensified the paradigm for lipid-clotting factor interactions.

    2 Results

    2.1 L-PC promotes fibrin (ogen)olysis by potentiating plasmin and tPA

    To determine whether L-PC has effect on coagulation,we initially evaluated the effects of L-PC on recalcification time (RT) of platelet-poor human plasma.As illustrated in Additional file 1: Figure S1A,stimulation with L-PC showed no effect on recalcification time.The coagulation cascade consists of extrinsic and intrinsic pathways,which can be assessed by prothrombin time (PT) and activated partial thromboplastin time (APTT) analysis,respectively.To confirm the effect of L-PC on coagulation,we further determined the influence of L-PC on PT and APTT.Similarly with the recalcification time,the results showed that L-PC stimulation did not significantly affect APTT (Additional file 1: Figure S1B) or PT(Additional file 1: Figure S1C).

    We next evaluated the impact of L-PC on fibrinolysis by measuring the enzymatic activity of plasmin and tPA against their respective chromogenic substrates.Results showed that L-PC enhanced the enzymatic activity of both plasmin (Fig.1A) and tPA (Fig.1B) against their chromogenic substrates,respectively.We further explored the direct interactions of L-PC with plasmin and tPA using SPR.As shown in Fig.1C and 1D,L-PC directly interacted with plasmin and tPA,with KD values of 6.47 × 10-9and 4.46 × 10-9M,respectively,showing high affinities.

    Fig. 1 l-palmitoylcarnitine promotes fibrin(ogen)olysis by potentiating plasmin and tPA.Compared with the control group,L-PC enhanced the abilities of plasmin (A) and tPA (B) to hydrolyze their chromogenic substrates.Surface plasmon resonance (SPR) analysis of interaction between L-PC and plasmin (C) and tPA (D) on sensor CM5 chip.L-PC could bind to plasmin and tPA with equilibrium dissociation constants (KD)of of 6.47 × 10-9 and 4.46 × 10-9 M,respectively.L-PC enhanced the abilities of plasmin (E) and tPA (F) to hydrolyze their physiological substrates.Data are mean ± SD of at least three independent experiments.*p < 0.05,**p < 0.01,***p < 0.001

    We further explored the impact of L-PC on plasmin-mediated fibrinolysis by applying plasmin with or without L-PC to the surface of preformed clots,with fibrinolysis then monitored using a Cytation 3 Cell Imaging Multi-Mode Reader (Biotek).As shown in Fig.1E,L-PC enhanced fibrin digestion in a dosedependent manner.Given that L-PC also promoted the enzymatic activity of tPA,we next examined the effect of L-PC on fibrinolysis in the presence of plasminogen and tPA.Similar to plasmin-mediated fibrinolysis,L-PC enhanced tPA-plasminogen-mediated fibrinolysis(Fig.1F).Collectively,these results suggest that L-PC facilitates fibrinolysis through the potentiation of plasmin and tPA activity.

    2.2 L-PC prevents thrombosis in vivo

    To assess the inhibitory effects of L-PC on thrombosis in vivo,an FeCl3-induced arterial thrombosis model was employed and carotid artery blood flow was examined using a laser perfusion imaging system.As shown in Fig.2A,carotid artery blood flow was nearly undetectable at 5 min after injury and totally undetectable at 10 min after injury in the L-PC-untreated control group.However,in the L-PC-stimulated groups (0.25-4 mg/kg),the formation of FeCl3-induced arterial thrombosis was significantly inhibited.The inhibitory effect of L-PC(4 mg/kg) on thrombosis formation was comparable to that observed in the heparin-treated group.Additionally,L-PC treatment significantly prolonged the mean time for carotid artery occlusion (Fig.2B).Notably,while the mean occlusion time for the L-PC-untreated group was 425.6 ± 18.21 s,this time was significantly extended by L-PC treatment (0.25,1,4 mg/kg) to 570.1 ± 62.73 s,586.9 ± 29.80 s,and 647.8 ± 42.62 s,respectively.These findings suggest that L-PC exhibits a dose-dependent inhibition of thrombosis formation.

    2.3 L-PC protects mice from ischemic stroke

    Ischemic stroke (IS) is recognized as one of the leading causes of disability and death worldwide and is typically precipitated by the occlusion of cerebral vasculature following a thrombotic event [11].Given the function of L-PC to facilitate fibrin(ogen)olysis and inhibit thrombosis as mentioned above,we explore anti-IS effects of L-PC by using a tMCAO mouse model to mimic IS.As illustrated in Fig.3A,L-PC treatment(1 and 4 mg/kg) induced a significant and progressive dose-dependent decrease in infarct volumes.On average,the infarct volumes in the L-PC-treated groups(1 mg/kg: 23.25 ± 1.849%,4 mg/kg: 11.47 ± 3.472%) were significantly smaller than that in the untreated group(47.38 ± 11.35%) (Fig.3B).Moreover,to evaluate the dysfunction of the blood-brain barrier (BBB),we assessed Evans blue extravasation in the L-PC-treated groups (1 and 4 mg/kg) as well as the untreated group (0 mg/kg)following IS.As shown in Fig.3C,L-PC administration prior to the induction of IS significantly attenuated the BBB dysfunction induced by cerebral ischemia-reperfusion.Consistently,the cerebral ischemia-reperfusioninduced area of Evans blue staining,indicative of BBB disruption,was significantly reduced under L-PC treatment (0 mg/kg: 32.69 ± 14.06%,1 mg/kg: 19.66 ± 3.128%,4 mg/kg: 9.59 ± 1.657%) (Fig.3D).Furthermore,the smaller infarct volumes observed in the L-PC-treated groups were associated with improved functional outcomes (Fig.3E: Bederson score;Fig.3F: grip test score).Taken together,these findings suggest that L-PC provides marked protection against IS.

    Fig. 3 l-palmitoylcarnitine protects mice from ischemic stroke by counteracting intracerebral thrombosis in the tMCAO model.Representative sample of brain slices with 2% TTC staining A and Evans blue staining (C) after tMCAO,and the quantification of the ischemic lesion size B in A and the Evans blue staining area D in C.Bederson score E and grip test score F after tMCAO.Data are mean ± SD of at least three independent experiments.***p < 0.001

    2.4 L-PC inhibits IS-induced inflammation

    The inflammatory response is known to be potentiated by clots and commonly occurs after IS [12,13].Thus,we further investigated the effects of L-PC treatment on IS-induced inflammation.As illustrated in Fig.4,compared to the sham-operated mice,the serum levels of IL-6,IL-1β,and TNF-α were significantly increased in the L-PC-untreated tMCAO group.Conversely,the levels of IL-6 (Fig.4A),IL-1β (Fig.4B),and TNF-α (Fig.4C)were significantly decreased in the L-PC-treated tMCAO groups.We also evaluated inflammation levels in the brain,and analogous to the serum results,significant reductions in tMCAO-induced IL-6 (Fig.4D),IL-1β(Fig.4E),and TNF-α (Fig.4F) levels were observed following L-PC treatment.Collectively,these findings suggest that L-PC effectively inhibits inflammation triggered by IS.

    2.5 L-PC induces little bleeding complications

    Bleeding is considered the most serious side effect of clinical anti-thrombotic drugs.To assess the potential bleeding complications associated with L-PC,we conducted a mouse tail bleeding test.As illustrated in Figure S2,L-PC exhibited minimal bleeding complications at the higher concentrations of 1 and 4 mg/kg,which was significantly lower compared to the heparin-treated group.This suggests that L-PC has a favorable bleeding profile as a potential anti-thrombotic agent.

    3 Discussion

    Fig. 4 l-palmitoylcarnitine inhibits inflammation in the tMCAO mouse model.Levels of cytokines of serum (A-C) and brain (D-F) after tMCAO with or without intravenous treatment of L-PC (1,4 mg/kg) were analyzed by ELISA.Higher levels of IL-6 (A,D),IL-1β (B,E),TNFα (C,F) in serum and brain induced by tMCAO were significantly attenuated with the treatment with L-PC.Data are mean ± SD of at least three independent experiments.*p < 0.05,**p < 0.01,***p < 0.001

    Thrombosis is implicated in the pathogenesis of many diseases,and strategies involving anticoagulation or fibrinolysis are crucial for the treatment and prevention of thrombotic disorders.In this study,we found that the endogenous metabolic molecule L-PC possesses potent anticoagulant properties by enhancing the enzymatic activity of plasmin and tPA,which was further confirmed by the significant inhibitory effects on the development of thrombosis and IS in vivo.The anticoagulant properties are mediated by the lipid-clotting factor interactions between L-PC and plasmin/tPA with high affinities.

    Both L-PC and L-C play important roles in mitochondrial β-oxidation,which is essential for maintaining energy homeostasis in the human body [14].As illustrated in Fig.1,L-PC could directly bind to two enzymes(plasmin and tPA) that are responsible for thrombolysis and fibrin(ogen)olysis.Through high-affinity interactions with plasmin (KD: 6.47 nM) and tPA (KD: 4.46 nM),L-PC significantly enhanced their hydrolytic abilities.As illustrated in Figs.2 and 3,in vivo mouse models further confirmed the anticoagulant functions of L-PC.Figure 2 shows that in the model of FeCl3-induced arterial thrombosis,even 0.25 mg/kg L-PC administration prolonged the occlusion time from 310 to 520 s,indicating significantly anti-thrombotic effects.In the tMCAO mouse model,1 mg/kg L-PC decreased the infract volume by 50% in the brains and significantly inhibited the production of inflammatory factors in the serum and brain tissues,showing potential anti-IS ability.

    Fatty acids demonstrate intricate interactions with the hematological system,with unsaturated fatty acids promoting fibrinolysis and saturated fatty acids displaying inhibitory effects [15].There are hundreds of minor lipids in plasma,many of which likely modulate clotting factor activities and affect thrombosis risk.For example,some minor abundance plasma lipids are found to modulate thrombin generation via direct effects on factor Xa,and some acylcarnitine lipids contained anticoagulant functions [10].Gamma carboxyglutamic acid (Gla) is a common domain in many vitamin K-dependent coagulation factors,such as prothrombin,factor X,factor IX,factor VII,protein C,and protein S.Gla domain is an interface for interacting with fatty acids [16-18].The current study identified strong interactions between L-PC and plasmin and t-PA.Further studies are necessary to determine the interface responsible for the interactions.Although many minor plasma lipids have been identified,only a few studies have been done to investigate the role of individual fatty acids in hemostasis [15].More investigations of procoagulant or anticoagulant effects of fatty acids and their derivatives will provide valuable insights into the paradigm for lipid clotting factor interactions.

    4 Conclusions

    In conclusion,we identified L-PC as an endogenous potentiator of the fibrinolytic system by enhancing the functions of plasmin and t-PA.Its administration showed significant therapeutic effects on thrombotic disorders,suggesting a potential to achieve beneficial effects by L-PC supplementation through dietary adjustments.

    5 Experimental section

    5.1 Blood coagulation time assay

    Blood recalcification time was measured in accordance with previous research [19].Briefly,19 μL of fresh plasma obtained from healthy human donors was mixed with 1 μL of L-PC (HY-113147A,MedChemExpress,USA.final concentrations of 0,25,and 50 μM) and 40 μL of HEPES buffer (20 mM HEPES,150 mM NaCl,pH 7.4) in 96-well plate.The plates were then incubated for 10 min in a 37 °C incubator,followed by the addition of 40 μL of preheated (37 °C) CaCl2solution (25 mM).The kinetic program was recorded using a Cytation 3 Cell Imaging Multi-Mode Reader (Biotek) to monitor absorbance at 650 nm every 30 s for 30 min.

    Activated partial thromboplastin time (APTT) is used to evaluate the functionality and integrity of the intrinsic and common coagulation pathways,while prothrombin time (PT) is used to detect the functionality and integrity of the extrinsic and common coagulation pathways.Here,we determined the effects of L-PC on APTT and PT using commercial kits according to the provided directions.Briefly,for the APTT assay,50 μL of APTT reagent (Beijing Reagan Biotechnology,China) and 50 μL of plasma were mixed with 5 μL of L-PC at different concentrations (0,25,50 μM).Clotting time was then recorded after the addition of 50 μL of preheated (37 °C) CaCl2(25 mM),with absorbance monitored at 650 nm using a Cytation 3 Cell Imaging Multi-Mode Reader (Biotek).For the PT assay,50 μL of plasma was mixed with 5 μL of L-PC at different concentrations (0,25,50 μM).Clotting time was then recorded after the addition of 100 μL of PT reagent (Nanjing Jiancheng Bioengineering Institute,China) preheated at 37 °C for 15 min,with then absorbance monitored at 650 nm using a Cytation 3 Cell Imaging Multi-Mode Reader (Biotek).

    5.2 Enzyme kinetic assays

    The enzymes used in this study were tissue-type fibrinogen activator and plasmin,with chromogenic substrates used for the enzyme kinetic experiments according to the method reported before [20].In brief,the enzymatic reactions were conducted in 50 mM Tris-HCl buffer (pH 7.8) at 37 °C.Initially,the proteases (plasmin:HPlasmin,Enzyme Research Laboratory,USA (30 nM);tPA: T0831,Sigma,USA (20 nM)) and serial dilutions of L-PC (6.25-100 μM) were incubated in buffer at 37 °C for 5 min,followed by the addition of their corresponding chromogenic substrates (CS-41,Hyphen Biomed,France (0.2 mM) for plasmin;CS-05,Hyphen Biomed,France (0.2 mM) for tPA) to initiate the reaction.The rate of substrate hydrolysis was monitored continuously at 405 nm.

    5.3 Fibrin polymer lysis assay

    The fibrin polymer lysis assay was used to examine the effects of L-PC on the activity of plasmin and tPA towards their physiological substrates according to the method reported before[21].Fibrin clots were formed by incubating fibrinogen with thrombin in buffer (50 mM Tris-HCl,pH 7.4,100 mM NaCl,and 5 mM CaCl2) at room temperature until turbidity reached a stable level.Plasmin or tPA plus plasminogen in the presence or absence of L-PC was gently layered on top of the fibrinogen polymer reaction mixture,with changes in turbidity at 450 nm monitored using a Cytation 3 Cell Imaging Multi-Mode Reader (Biotek).

    5.4 Surface plasmon resonance (SPR) analysis

    SPR analysis was performed according to the manufacturer’s instructions.In brief,a CM5 sensor chip (29149603,Cytiva,USA) was first activated with 0.4 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and 10 mM N-hydroxysuccinimide at a flow rate of 5 μL/min for 20 min.Plasmin (HPlasmin,Enzyme Research Laboratory,USA) or tPA (HY-P71051,MedChemExpress,USA),diluted to a concentration of 100 μg/mL using sodium acetate buffer (10 mM,pH 5),flowed across the activated surface,allowing coupling with the chip until a target response value (RU) of 12 000 was reached.The remaining activated sites on the chip were blocked by 75 μL of ethanolamine (1 M,pH 8.5).Real-time detection was recorded using a Biacore S200 instrument (USA) at a flow rate of 10 μL/min.Subsequently,to detect the equilibrium dissociation constant (KD),serially diluted L-PC(12.5,25,50,100,200 μM in 0.01 M phosphate-buffered saline (PBS),pH 7.4) was applied to analyze its interactions with plasmin or tPA coupled on the chip surface using the BIA evaluation program.

    5.5 Bleeding time test

    Male C57BL/6 mice (6 weeks old) were randomly divided into five groups (n=6 per group): saline-treated group,three L-PC-treated groups (concentrations of 0.25,1,4 mg/kg),and sodium heparin-treated positive control group (2 500 U/kg).After 10-min intravenous administration of the respective drugs via the tail vein,the tails were cut at a distance of 2 mm from the tip and immersed in saline at 37 °C.The time taken for continuous blood flow to cease was recorded as bleeding time.

    5.6 FeCl3-induced mouse thrombosis model

    Male C57BL/6 J mice (6 weeks old) were anesthetized with 3% pentobarbital sodium (80 mg/kg) and fixed in a supine position.The left carotid artery (CCA) was exposed through a midline neck incision.Subsequently,four groups were established,each receiving different concentrations of L-PC (0,0.25,1,4 mg/kg) administered via tail vein injections.After a 10-min interval,carotid arterial thrombosis was induced by placing a filter paper disc (diameter 5.0 mm) soaked in 10% FeCl3onto the artery for 2 min.Blood flow was monitored using a laserspeckle blood flow imaging system (RFLSI Pro;RWD Life Science).

    5.7 Transient MCAO (tMCAO)

    5.7.1 Assessment of functional outcome

    Male C57BL/6 J mice (6 weeks old) were anesthetized with 3% pentobarbital sodium (80 mg/kg) and fixed in a supine position.The skin along the midline of the neck was incised to expose the external and internal carotid arteries.A standardized silicon rubber-coated nylon monofilament (6023910PK10;Doccol,Sharon,MA,USA) was carefully inserted into the left common carotid artery and advanced via the internal carotid artery to occlude the origin of the left middle cerebral artery,inducing ischemia.Subsequently,four groups were established,each receiving different concentrations of L-PC(0,0.25,1,or 4 mg/kg) administered 10 min prior to reperfusion.Reperfusion was initiated by removing the occluding filament 60 min after its insertion.After 24 h of modeling,neurological assessments,including Bederson score and grip test,were performed following previously established protocols [22].

    5.7.2 Measurement of infarct size and volume

    The mice were sacrificed 24 h after tMCAO and five 2-mm-thick coronal brain sections were obtained.The brain slices were stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC,Sigma,USA) in a dark environment at 37 °C for 10 min.TTC reacts with intact mitochondrial respiratory enzymes,resulting in the unaffected brain regions appearing bright red and the infarct areas exhibiting a pale coloration.The extent of infarction in the brain sections was estimated by calculating the pale area.The infarct volume ratio was quantified using Image Pro Plus v6.0 (Media Cybernetics,Bethesda,MD,USA).

    5.7.3 Evans blue staining

    Mice were injected with 2% Evans blue (R31047,Yuanye,China) in the tail vein 2 h before sacrifice.Brain sections were taken to calculate the area of Evans blue staining using Image Pro Plus v6.0 (Media Cybernetics,Bethesda,MD,USA).

    5.7.4 Enzyme-linked immunosorbent assay (ELISA)

    Male C57BL/6 J mice (6 weeks old) were sacrificed 24 h after tMCAO,followed by the collection of brain tissue and blood.Mouse IL-1β ELISA kit(DG30045M-96 T,Dogesce,China),IL-6 ELISA kit(DG30062M-96 T,Dogesce,China),and TNF-α ELISA kit (DG30048M-96 T,Dogesce,China) were used to detect the levels of inflammatory factors in brain tissue and blood samples according to the manufacturer’s instructions.

    5.8 Statistical analyses

    Data obtained from independent experiments are presented as mean ± standard deviation (SD).For normal continuous variables,one-way analysis of variance(ANOVA) was used.All analyses were conducted using GraphPad Prism v5.Asterisks represent p-value classifications: *p< 0.05;**p< 0.01,and ***p< 0.001.

    Supplementary Information

    The online version contains supplementary material available at https:// doi.org/ 10.1007/ s13659-023-00413-z.

    Additional file 1:Fig.S1.Effects of L-PC on recalcification time,APTT and PT.Compared with the control group,the recalcification time (A) was similar with or without the stimulation by L-PC at the concentration of 25 and 50 μM.Using APTT and PT kit,effects of L-PC on coagulation cascade was determined.Compared with the L-PC untreated group,the APTT (B)and PT (C) were showed no significant difference after stimulated with L-PC with the concentration of 25 and 50 μM.Fig.S2.Effects of L-PC on bleeding.Mouse tail bleeding model was created,which was used to determine the bleeding risk of L-PC.At the higher concentration (1 and 4 mg/kg),L-PC showed minimal bleeding complications,which was much lower compared to that of the heparin-treated group.Data are mean ± SD of at least three independent experiments.**p< 0.01,***p< 0.001.

    Author contributions

    JS and ZD designed the study,wrote and revised the manuscript.JY,LC and YW performed most of the experiments and wrote the manuscript.QZ and XT participated in some of the experiments and assisted in the analysis of the data.All authors have read and agreed to the published version of the manuscript.

    Funding

    This work was supported by Priority Union Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University(202101AC070461).

    Data availability

    All the data supporting the findings of this study are available within the article and/or its supplementary materials.

    Declarations

    Ethics approval

    All animal experiments were approved by the Animal Care and Welfare Committee of Kunming Medical University (kmmu20211235) on 6 July 2021,and conformed to the US National Institutes of Health’s Guide for the Care and Use of Laboratory Animals (National Academies Press,8th Edition,2011).All necessary measures were taken to ensure the welfare of the animals during the experimental protocols.The experimental C57BL/6 J mice (males,6 weeks old),purchased from SPF Biotechnology Co.(Beijing,China),were housed in a pathogen-free environment within sterile isolators in the laboratory under a 12 h light-12 h dark cycle at 24 °C.All mice were provided with autoclaved food and water.

    Competing interests

    The authors declare no competing interests.

    Author details

    1Department of Anesthesiology,First Affiliated Hospital of Kunming Medical University,Kunming 650032,China.2State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China.3College of Life Sciences,Nanjing Agricultural University,Nanjing 210095,China.4Small Molecule Drugs Sichuan Key Laboratory,Institute of Materia Medica,School of Pharmacy,Chengdu Medical College,Chengdu 610500,China.5School of Basic Medicine,Qingdao University,Qingdao 266071,Shandong,China.

    Received:18 September 2023

    Accepted:25 October 2023

    国产成人精品福利久久| 亚洲情色 制服丝袜| 国产高清不卡午夜福利| 国产精品一区二区精品视频观看| 99热国产这里只有精品6| 波野结衣二区三区在线| 国产精品熟女久久久久浪| 午夜av观看不卡| 男人添女人高潮全过程视频| 国产精品三级大全| 久久毛片免费看一区二区三区| 丰满迷人的少妇在线观看| 90打野战视频偷拍视频| 激情视频va一区二区三区| 欧美中文综合在线视频| 99国产精品免费福利视频| 99九九在线精品视频| 纵有疾风起免费观看全集完整版| 蜜桃国产av成人99| 熟女少妇亚洲综合色aaa.| 中文字幕人妻丝袜制服| 悠悠久久av| 亚洲av福利一区| 亚洲久久久国产精品| av不卡在线播放| 国产一区二区在线观看av| 久久鲁丝午夜福利片| 日韩免费高清中文字幕av| 亚洲av国产av综合av卡| 悠悠久久av| 99久久99久久久精品蜜桃| 最黄视频免费看| 欧美精品高潮呻吟av久久| 伦理电影免费视频| 捣出白浆h1v1| 国产精品嫩草影院av在线观看| 成人国语在线视频| 国产免费现黄频在线看| 国产片特级美女逼逼视频| 香蕉国产在线看| 国产又爽黄色视频| 中文字幕av电影在线播放| 亚洲精品日韩在线中文字幕| 丝袜喷水一区| 精品第一国产精品| 女人高潮潮喷娇喘18禁视频| 自拍欧美九色日韩亚洲蝌蚪91| 蜜桃在线观看..| 日日爽夜夜爽网站| 老鸭窝网址在线观看| 成年动漫av网址| 久久精品亚洲熟妇少妇任你| 成人黄色视频免费在线看| 精品视频人人做人人爽| av国产久精品久网站免费入址| 久久久精品国产亚洲av高清涩受| 人人妻人人澡人人爽人人夜夜| 亚洲精华国产精华液的使用体验| 国产一区亚洲一区在线观看| www.av在线官网国产| 国产亚洲一区二区精品| av国产精品久久久久影院| 日韩av在线免费看完整版不卡| 国产爽快片一区二区三区| 91老司机精品| 操出白浆在线播放| 亚洲,欧美,日韩| 777久久人妻少妇嫩草av网站| 久久久久国产一级毛片高清牌| 天堂中文最新版在线下载| 欧美97在线视频| 午夜日韩欧美国产| 精品国产乱码久久久久久小说| 久久女婷五月综合色啪小说| 久久久久久人妻| 欧美日韩视频高清一区二区三区二| 人成视频在线观看免费观看| 国产熟女欧美一区二区| www.av在线官网国产| 国产乱来视频区| 曰老女人黄片| 黄片播放在线免费| 色婷婷av一区二区三区视频| 大香蕉久久成人网| 1024视频免费在线观看| 亚洲成av片中文字幕在线观看| av视频免费观看在线观看| 一个人免费看片子| 亚洲少妇的诱惑av| 韩国av在线不卡| 女人爽到高潮嗷嗷叫在线视频| 最新在线观看一区二区三区 | 在线观看免费高清a一片| 亚洲av欧美aⅴ国产| 亚洲婷婷狠狠爱综合网| 欧美黄色片欧美黄色片| 麻豆精品久久久久久蜜桃| 十八禁人妻一区二区| 国产成人午夜福利电影在线观看| 少妇人妻精品综合一区二区| 国产极品天堂在线| 日韩 欧美 亚洲 中文字幕| 老司机深夜福利视频在线观看 | 热re99久久国产66热| 亚洲欧美成人综合另类久久久| 午夜福利在线免费观看网站| 日韩中文字幕欧美一区二区 | 久久亚洲国产成人精品v| 天堂俺去俺来也www色官网| 曰老女人黄片| 国产 精品1| √禁漫天堂资源中文www| 亚洲美女黄色视频免费看| 亚洲七黄色美女视频| a级片在线免费高清观看视频| av卡一久久| 久久99一区二区三区| 深夜精品福利| 亚洲专区中文字幕在线 | 极品少妇高潮喷水抽搐| 久久久久网色| 美国免费a级毛片| 国产亚洲欧美精品永久| 国产精品久久久久久人妻精品电影 | 亚洲熟女毛片儿| 黄片无遮挡物在线观看| 女性生殖器流出的白浆| 欧美变态另类bdsm刘玥| 十八禁高潮呻吟视频| 黄网站色视频无遮挡免费观看| av福利片在线| 国产欧美亚洲国产| 蜜桃在线观看..| 久久精品国产综合久久久| 日韩人妻精品一区2区三区| 精品国产一区二区三区四区第35| 91精品伊人久久大香线蕉| 国产精品无大码| 人妻一区二区av| 黄网站色视频无遮挡免费观看| 人人澡人人妻人| 欧美在线一区亚洲| 在线观看一区二区三区激情| 咕卡用的链子| 亚洲av福利一区| 91精品三级在线观看| 欧美精品亚洲一区二区| 亚洲av福利一区| 亚洲av国产av综合av卡| 制服丝袜香蕉在线| 日韩视频在线欧美| 亚洲国产精品成人久久小说| 亚洲欧洲日产国产| 久久人妻熟女aⅴ| 18禁观看日本| 最近中文字幕高清免费大全6| 久久这里只有精品19| 日韩,欧美,国产一区二区三区| 亚洲熟女毛片儿| 青春草亚洲视频在线观看| 亚洲av中文av极速乱| 黄色一级大片看看| 超碰97精品在线观看| 精品一区在线观看国产| 美女大奶头黄色视频| 欧美激情 高清一区二区三区| 中文乱码字字幕精品一区二区三区| 18禁裸乳无遮挡动漫免费视频| 久久人妻熟女aⅴ| 1024香蕉在线观看| 久久久精品区二区三区| 国产片内射在线| 国产欧美亚洲国产| 妹子高潮喷水视频| 国产成人a∨麻豆精品| 国产欧美日韩综合在线一区二区| 宅男免费午夜| 晚上一个人看的免费电影| 天天躁日日躁夜夜躁夜夜| 菩萨蛮人人尽说江南好唐韦庄| 午夜福利免费观看在线| 新久久久久国产一级毛片| 午夜激情av网站| 亚洲欧洲精品一区二区精品久久久 | 一级毛片电影观看| 国产精品偷伦视频观看了| 19禁男女啪啪无遮挡网站| 亚洲美女搞黄在线观看| 国精品久久久久久国模美| 日本vs欧美在线观看视频| 在线观看免费午夜福利视频| 叶爱在线成人免费视频播放| 韩国精品一区二区三区| 久久久精品区二区三区| 久久ye,这里只有精品| 国产极品天堂在线| 亚洲精品美女久久av网站| 亚洲精华国产精华液的使用体验| 国产日韩欧美视频二区| 啦啦啦视频在线资源免费观看| 日韩av免费高清视频| 国产精品 国内视频| 国产成人午夜福利电影在线观看| 久久精品久久久久久久性| 一本久久精品| 亚洲国产欧美在线一区| 亚洲av欧美aⅴ国产| 久久国产精品大桥未久av| 精品国产乱码久久久久久小说| 国产成人午夜福利电影在线观看| 狂野欧美激情性bbbbbb| 一区二区三区四区激情视频| 日日撸夜夜添| 亚洲欧美一区二区三区黑人| 如何舔出高潮| 亚洲欧美精品综合一区二区三区| svipshipincom国产片| 又大又爽又粗| 亚洲男人天堂网一区| 午夜免费观看性视频| 国产黄色视频一区二区在线观看| 成年女人毛片免费观看观看9 | 亚洲国产看品久久| 水蜜桃什么品种好| 最近中文字幕高清免费大全6| 啦啦啦在线观看免费高清www| 欧美国产精品一级二级三级| 欧美另类一区| 日本av免费视频播放| 黄色一级大片看看| 99国产精品免费福利视频| 国产乱人偷精品视频| 水蜜桃什么品种好| 国产亚洲av高清不卡| av国产精品久久久久影院| 成人国语在线视频| bbb黄色大片| 男女免费视频国产| 激情视频va一区二区三区| 亚洲婷婷狠狠爱综合网| 久久久久视频综合| 捣出白浆h1v1| 色婷婷久久久亚洲欧美| 午夜日韩欧美国产| √禁漫天堂资源中文www| 一区二区三区精品91| 久久精品国产亚洲av高清一级| 国产不卡av网站在线观看| 欧美日韩亚洲高清精品| 日韩 亚洲 欧美在线| 日日摸夜夜添夜夜爱| 色综合欧美亚洲国产小说| 一区二区三区精品91| 国产av码专区亚洲av| 人成视频在线观看免费观看| 美女大奶头黄色视频| av在线观看视频网站免费| 亚洲av欧美aⅴ国产| 丝袜人妻中文字幕| 欧美精品一区二区免费开放| 亚洲精品aⅴ在线观看| 久久久亚洲精品成人影院| 亚洲av中文av极速乱| 亚洲精品自拍成人| 免费观看a级毛片全部| 少妇人妻 视频| 少妇的丰满在线观看| 欧美另类一区| 日韩大片免费观看网站| 国产亚洲午夜精品一区二区久久| 各种免费的搞黄视频| 欧美日韩一级在线毛片| 狠狠婷婷综合久久久久久88av| 久久国产精品大桥未久av| 叶爱在线成人免费视频播放| 日本91视频免费播放| 97人妻天天添夜夜摸| 免费黄色在线免费观看| 一级黄片播放器| 99久久综合免费| 黄色毛片三级朝国网站| 咕卡用的链子| 曰老女人黄片| 啦啦啦啦在线视频资源| 亚洲三区欧美一区| 国产亚洲一区二区精品| 最近2019中文字幕mv第一页| 超碰97精品在线观看| 天堂俺去俺来也www色官网| 最近的中文字幕免费完整| 日韩成人av中文字幕在线观看| 成人影院久久| 久久影院123| av一本久久久久| 国产人伦9x9x在线观看| svipshipincom国产片| 赤兔流量卡办理| 精品人妻熟女毛片av久久网站| 国产男女超爽视频在线观看| 看免费成人av毛片| 人人妻人人澡人人爽人人夜夜| 精品国产露脸久久av麻豆| 91aial.com中文字幕在线观看| 欧美亚洲 丝袜 人妻 在线| 亚洲伊人久久精品综合| 男女边吃奶边做爰视频| 欧美少妇被猛烈插入视频| 啦啦啦视频在线资源免费观看| 毛片一级片免费看久久久久| 99久国产av精品国产电影| 一边摸一边做爽爽视频免费| 啦啦啦啦在线视频资源| 伊人久久国产一区二区| 秋霞伦理黄片| 国产成人精品在线电影| 免费观看人在逋| 欧美激情高清一区二区三区 | 秋霞伦理黄片| 欧美激情 高清一区二区三区| 国产成人一区二区在线| 男的添女的下面高潮视频| 成人国产av品久久久| 天天躁日日躁夜夜躁夜夜| 午夜福利视频精品| 777久久人妻少妇嫩草av网站| 亚洲专区中文字幕在线 | 狠狠婷婷综合久久久久久88av| 日韩大码丰满熟妇| 国产欧美日韩综合在线一区二区| 少妇的丰满在线观看| 久久久久人妻精品一区果冻| 中国三级夫妇交换| www.精华液| 日韩av免费高清视频| 欧美精品av麻豆av| 日韩制服骚丝袜av| 日本午夜av视频| 中文字幕色久视频| 一级毛片 在线播放| 一本—道久久a久久精品蜜桃钙片| 国产国语露脸激情在线看| 看非洲黑人一级黄片| 狂野欧美激情性xxxx| 国产欧美日韩综合在线一区二区| 中文字幕人妻熟女乱码| 国产精品一国产av| 亚洲色图 男人天堂 中文字幕| 亚洲美女视频黄频| 少妇人妻 视频| 一本色道久久久久久精品综合| 又大又黄又爽视频免费| 一区在线观看完整版| 各种免费的搞黄视频| 中国三级夫妇交换| 中文精品一卡2卡3卡4更新| 亚洲国产av影院在线观看| 亚洲美女视频黄频| 夫妻午夜视频| 黑人猛操日本美女一级片| 制服人妻中文乱码| 亚洲情色 制服丝袜| 精品久久久精品久久久| 欧美成人精品欧美一级黄| 侵犯人妻中文字幕一二三四区| 2021少妇久久久久久久久久久| www日本在线高清视频| 欧美 亚洲 国产 日韩一| 97精品久久久久久久久久精品| 少妇人妻精品综合一区二区| 少妇 在线观看| 麻豆乱淫一区二区| 国产精品久久久久成人av| 老司机在亚洲福利影院| 九色亚洲精品在线播放| 一级a爱视频在线免费观看| 一区二区三区激情视频| 亚洲熟女毛片儿| 午夜福利乱码中文字幕| 日韩电影二区| 一区福利在线观看| 欧美黑人精品巨大| 宅男免费午夜| 免费高清在线观看日韩| 中文字幕另类日韩欧美亚洲嫩草| 又大又黄又爽视频免费| 精品久久久久久电影网| 欧美少妇被猛烈插入视频| 中国国产av一级| 欧美久久黑人一区二区| 黄色怎么调成土黄色| 久久97久久精品| 777米奇影视久久| 亚洲av日韩精品久久久久久密 | 国产麻豆69| 极品人妻少妇av视频| 99热网站在线观看| 高清av免费在线| 欧美另类一区| av不卡在线播放| 久久久久网色| 精品亚洲乱码少妇综合久久| 国产精品久久久久久精品古装| 最近的中文字幕免费完整| 韩国高清视频一区二区三区| 老司机靠b影院| 少妇被粗大的猛进出69影院| 国产毛片在线视频| 亚洲一码二码三码区别大吗| 国产精品久久久久久人妻精品电影 | 成人免费观看视频高清| 国产av精品麻豆| 亚洲一码二码三码区别大吗| 亚洲人成电影观看| 久久久精品国产亚洲av高清涩受| 久久97久久精品| 精品亚洲乱码少妇综合久久| 五月开心婷婷网| 男女免费视频国产| 91国产中文字幕| 久久这里只有精品19| 国产激情久久老熟女| 久久久久久久精品精品| 免费日韩欧美在线观看| 久久久精品区二区三区| 午夜免费观看性视频| 日韩精品免费视频一区二区三区| 大香蕉久久网| 久久精品国产亚洲av高清一级| 最近最新中文字幕免费大全7| 国产亚洲最大av| 好男人视频免费观看在线| 丝袜脚勾引网站| 18禁观看日本| 午夜福利乱码中文字幕| 色94色欧美一区二区| 最黄视频免费看| 久久青草综合色| 国产精品久久久久久精品古装| 人妻一区二区av| 这个男人来自地球电影免费观看 | 亚洲欧美激情在线| 伦理电影大哥的女人| 一区在线观看完整版| 久久综合国产亚洲精品| 麻豆精品久久久久久蜜桃| 另类亚洲欧美激情| 亚洲精品自拍成人| 黑人猛操日本美女一级片| 最近2019中文字幕mv第一页| 日韩电影二区| 亚洲精品日韩在线中文字幕| 丰满乱子伦码专区| 国产无遮挡羞羞视频在线观看| 国产又色又爽无遮挡免| 亚洲精品日韩在线中文字幕| 一级毛片电影观看| 亚洲精品第二区| 国产伦理片在线播放av一区| 亚洲av国产av综合av卡| 咕卡用的链子| 国产亚洲精品第一综合不卡| 国产有黄有色有爽视频| 各种免费的搞黄视频| 高清欧美精品videossex| 日本欧美视频一区| 51午夜福利影视在线观看| 伦理电影免费视频| 亚洲欧美激情在线| 亚洲国产日韩一区二区| 久久精品久久久久久噜噜老黄| 在线观看免费高清a一片| 国产欧美亚洲国产| 久久99一区二区三区| 亚洲欧美成人综合另类久久久| 亚洲av电影在线观看一区二区三区| 中文字幕av电影在线播放| 亚洲四区av| 国产亚洲av片在线观看秒播厂| av.在线天堂| 色吧在线观看| 国产男人的电影天堂91| 黄片播放在线免费| 9色porny在线观看| 亚洲欧美清纯卡通| 麻豆乱淫一区二区| 精品少妇一区二区三区视频日本电影 | 一区二区三区四区激情视频| 亚洲欧美一区二区三区久久| 久久久精品区二区三区| 美女中出高潮动态图| 男女之事视频高清在线观看 | av片东京热男人的天堂| 免费看av在线观看网站| 满18在线观看网站| 热re99久久国产66热| 亚洲精品一二三| 最黄视频免费看| 黑人巨大精品欧美一区二区蜜桃| 黄色视频不卡| 中文精品一卡2卡3卡4更新| 久久久久久人人人人人| 国产成人精品久久二区二区91 | 精品国产一区二区三区久久久樱花| 欧美日韩亚洲国产一区二区在线观看 | 男人舔女人的私密视频| 国产午夜精品一二区理论片| 香蕉国产在线看| xxxhd国产人妻xxx| 在线亚洲精品国产二区图片欧美| 国产免费福利视频在线观看| 国产人伦9x9x在线观看| 韩国精品一区二区三区| 纵有疾风起免费观看全集完整版| 黑人欧美特级aaaaaa片| 国产亚洲av片在线观看秒播厂| 人妻一区二区av| 成人国产麻豆网| 午夜福利影视在线免费观看| www.自偷自拍.com| 亚洲成人av在线免费| 国产亚洲欧美精品永久| 亚洲欧美一区二区三区国产| 亚洲欧美色中文字幕在线| 美女大奶头黄色视频| 人人妻人人添人人爽欧美一区卜| 超碰97精品在线观看| 女人久久www免费人成看片| av片东京热男人的天堂| 成年人午夜在线观看视频| 欧美变态另类bdsm刘玥| 99热国产这里只有精品6| 精品第一国产精品| 少妇 在线观看| 亚洲中文av在线| 爱豆传媒免费全集在线观看| 777久久人妻少妇嫩草av网站| 男女床上黄色一级片免费看| 国产精品一国产av| 夫妻午夜视频| 丝袜脚勾引网站| 天天影视国产精品| 国产成人精品久久久久久| 亚洲国产av新网站| 久久久久久久精品精品| 亚洲国产精品成人久久小说| 精品人妻一区二区三区麻豆| 精品人妻熟女毛片av久久网站| 亚洲av国产av综合av卡| 午夜久久久在线观看| 一本久久精品| 99久久人妻综合| 五月开心婷婷网| 欧美日韩视频精品一区| 成人漫画全彩无遮挡| 毛片一级片免费看久久久久| 国产无遮挡羞羞视频在线观看| 午夜福利视频在线观看免费| 亚洲av电影在线进入| 亚洲欧美成人综合另类久久久| 日韩成人av中文字幕在线观看| 777久久人妻少妇嫩草av网站| 国产野战对白在线观看| 男人添女人高潮全过程视频| 国产男女超爽视频在线观看| 欧美人与性动交α欧美精品济南到| 久久久久精品国产欧美久久久 | 欧美日韩亚洲国产一区二区在线观看 | 99re6热这里在线精品视频| 欧美日韩亚洲国产一区二区在线观看 | 蜜桃国产av成人99| 波野结衣二区三区在线| 爱豆传媒免费全集在线观看| 一级黄片播放器| 人妻一区二区av| 久久精品久久久久久噜噜老黄| 精品久久久精品久久久| 男女无遮挡免费网站观看| 天天躁夜夜躁狠狠久久av| 激情五月婷婷亚洲| 晚上一个人看的免费电影| 最近中文字幕2019免费版| 免费久久久久久久精品成人欧美视频| 亚洲欧美日韩另类电影网站| 亚洲男人天堂网一区| 日韩不卡一区二区三区视频在线| 国产在视频线精品| 欧美变态另类bdsm刘玥| 69精品国产乱码久久久| 卡戴珊不雅视频在线播放| 80岁老熟妇乱子伦牲交| 波多野结衣一区麻豆| 伦理电影免费视频| 18禁动态无遮挡网站| 精品人妻熟女毛片av久久网站| 色婷婷av一区二区三区视频| 久久久久网色| av.在线天堂| 一级片'在线观看视频| 久久久久久免费高清国产稀缺| 国产男女超爽视频在线观看| 国产麻豆69| 亚洲三区欧美一区| 天天添夜夜摸| 国产精品一区二区在线不卡| 久久久久久久大尺度免费视频| 欧美日韩一区二区视频在线观看视频在线| 久久热在线av| 国产乱人偷精品视频| 久久99精品国语久久久| 国产片内射在线| 天天躁夜夜躁狠狠躁躁| a级毛片在线看网站| 国产免费视频播放在线视频| 欧美av亚洲av综合av国产av | 大码成人一级视频|